CIK: 0001056807 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 14, 2017
Total Value ($000): $786,726 (97.5% shares, 2.5% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARRAY BIOPHARMA INC | 6,402,525 | $78,751 | 10.0% | $6.82 | — | COM | 04269X105 |
| — | BLUEPRINT MEDICINES CORP | 1,007,354 | $70,182 | 8.9% | $25.16 | — | COM | 09627Y109 |
| — | CHEMOCENTRYX INC | 7,587,416 | $56,299 | 7.2% | $8.94 | — | COM | 16383L106 |
| ANAB | ANAPTYSBIO INC | 1,379,134 | $48,201 | 6.1% | $23.32 | +15.7% | COM | 032724106 |
| — | CONCERT PHARMACEUTICALS INC | 3,135,289 | $46,246 | 5.9% | $14.18 | — | COM | 206022105 |
| — | GLYCOMIMETICS INC | 3,229,856 | $45,186 | 5.7% | $7.84 | — | COM | 38000Q102 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 2,820,000 | $44,471 | 5.7% | $13.76 | 0.0% | COM CL A | 46333X108 |
| CTMX | CYTOMX THERAPEUTICS INC | 2,230,898 | $40,535 | 5.2% | $14.24 | +9.6% | COM | 23284F105 |
| XOMA | XOMA CORP DEL | 1,502,800 | $29,530 | 3.8% | $5.35 | +108.6% | COM NEW | 98419J206 |
| — | BIOLINERX LTD | 25,995,575 | $29,115 | 3.7% | $1.01 | — | SPONSORED ADR | 09071M106 |
| — | CTI BIOPHARMA CORP | 8,596,357 | $27,422 | 3.5% | $3.77 | — | COM NEW | 12648L601 |
| — | LOXO ONCOLOGY INC | 238,386 | $21,960 | 2.8% | $53.87 | — | COM | 548862101 |
| KURA | KURA ONCOLOGY INC | 1,353,846 | $20,240 | 2.6% | $9.39 | 0.0% | COM | 50127T109 |
| — | ONCOMED PHARMACEUTICALS INC | 4,400,289 | $19,889 | 2.5% | $8.77 | — | COM | 68234X102 |
| — | ZEALAND PHARMA A S | 1,000,000 | $19,200 | 2.4% | $19.20 | — | SPONSORED ADR | 98920Y304 |
| CYTK | CYTOKINETICS INC | 1,241,021 | $17,995 | 2.3% | $7.03 | +94.3% | COM NEW | 23282W605 |
| — | PIERIS PHARMACEUTICALS INC | 2,986,562 | $17,203 | 2.2% | $3.18 | — | COM | 720795103 |
| — | REGULUS THERAPEUTICS INC | 12,949,229 | $16,187 | 2.1% | $1.22 | — | COM | 75915K101 |
| — | INTRA CELLULAR THERAPIES INC | 950,000 | $14,991 | 1.9% | $15.78 | — | COM | 46116X101 |
| — | TOCAGEN INC | 1,063,028 | $13,245 | 1.7% | $12.03 | — | COM | 888846102 |
| — | CASCADIAN THERAPEUTICS INC | 3,133,224 | $12,815 | 1.6% | $4.31 | — | COM NEW | 14740B606 |
| — | SPRING BK PHARMACEUTICALS INC | 652,676 | $10,991 | 1.4% | $13.73 | — | COM | 849431101 |
| XENE | XENON PHARMACEUTICALS INC | 3,588,830 | $10,587 | 1.3% | $8.35 | -62.9% | COM | 98420N105 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 7,866,108 | $10,462 | 1.3% | $3.51 | -64.7% | COM | 45665G303 |
| — | GTX INC DEL | 1,108,433 | $9,111 | 1.2% | $5.28 | — | COM NEW | 40052B207 |
| — | FORWARD PHARMA A/S | 1,455,117 | $8,571 | 1.1% | $20.16 | — | SPONSORED ADR | 34986J105 |
| — | ARQULE INC | 7,400,128 | $8,214 | 1.0% | $1.87 | — | COM | 04269E107 |
| — | ALPINE IMMUNE SCIENCES INC | 675,759 | $7,839 | 1.0% | $11.60 | — | COM | 02083G100 |
| CRVS | CORVUS PHARMACEUTICALS INC | 459,396 | $7,323 | 0.9% | $11.95 | +15.8% | COM | 221015100 |
| — | MOLECULAR TEMPLATES INC | 724,132 | $5,047 | 0.6% | $6.97 | — | COM | 608550109 |
| — | OREXIGEN THERAPEUTICS INC | 10,000,000 | $4,769 | 0.6% | $0.27 | — | NOTE 2.750%12/0 | 686164AB0 |
| — | SUNESIS PHARMACEUTICALS INC | 2,043,196 | $3,964 | 0.5% | $3.60 | — | COM PAR | 867328700 |
| — | CONTRAFECT CORP | 3,500,000 | $3,885 | 0.5% | $1.11 | — | COM | 212326102 |
| — | ADURO BIOTECH INC | 184,764 | $1,968 | 0.3% | $11.40 | — | COM | 00739L101 |
| — | OREXIGEN THERAPEUTICS INC | 734,976 | $1,558 | 0.2% | $3.32 | — | COM NEW | 686164302 |
| ANTH | ANTHERA PHARMACEUTICALS INC | 1,006,507 | $1,449 | 0.2% | $2.24 | -36.6% | COM | 03674U300 |
| — | PAIN THERAPEUTICS INC | 325,508 | $1,325 | 0.2% | $4.12 | — | COM NEW | 69562K506 |